Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. vs ADVANCED ENZYME TECHNOLOGIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MARKSANS PHARMA. ADVANCED ENZYME TECHNOLOGIES MARKSANS PHARMA./
ADVANCED ENZYME TECHNOLOGIES
 
P/E (TTM) x 21.5 27.9 76.9% View Chart
P/BV x 3.9 3.1 125.1% View Chart
Dividend Yield % 0.3 1.4 22.9%  

Financials

 MARKSANS PHARMA.   ADVANCED ENZYME TECHNOLOGIES
EQUITY SHARE DATA
    MARKSANS PHARMA.
Mar-23
ADVANCED ENZYME TECHNOLOGIES
Mar-23
MARKSANS PHARMA./
ADVANCED ENZYME TECHNOLOGIES
5-Yr Chart
Click to enlarge
High Rs74328 22.7%   
Low Rs39225 17.2%   
Sales per share (Unadj.) Rs40.948.3 84.5%  
Earnings per share (Unadj.) Rs5.99.3 63.0%  
Cash flow per share (Unadj.) Rs7.012.4 56.3%  
Dividends per share (Unadj.) Rs0.505.00 10.0%  
Avg Dividend yield %0.91.8 48.9%  
Book value per share (Unadj.) Rs38.5110.5 34.9%  
Shares outstanding (eoy) m453.16111.82 405.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.45.7 24.2%   
Avg P/E ratio x9.729.8 32.4%  
P/CF ratio (eoy) x8.122.3 36.3%  
Price / Book Value ratio x1.52.5 58.6%  
Dividend payout %8.553.8 15.9%   
Avg Mkt Cap Rs m25,63130,939 82.8%   
No. of employees `000NANA-   
Total wages/salary Rs m2,3941,148 208.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m18,5215,406 342.6%  
Other income Rs m593255 233.0%   
Total revenues Rs m19,1155,661 337.7%   
Gross profit Rs m3,3931,534 221.1%  
Depreciation Rs m519350 148.0%   
Interest Rs m9135 262.4%   
Profit before tax Rs m3,3771,404 240.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m723365 198.1%   
Profit after tax Rs m2,6531,039 255.4%  
Gross profit margin %18.328.4 64.6%  
Effective tax rate %21.426.0 82.3%   
Net profit margin %14.319.2 74.6%  
BALANCE SHEET DATA
Current assets Rs m16,9977,221 235.4%   
Current liabilities Rs m3,654776 471.0%   
Net working cap to sales %72.0119.2 60.4%  
Current ratio x4.79.3 50.0%  
Inventory Days Days6255 2.2%  
Debtors Days Days8268 121.3%  
Net fixed assets Rs m5,2466,884 76.2%   
Share capital Rs m453224 202.6%   
"Free" reserves Rs m16,99812,127 140.2%   
Net worth Rs m17,45212,351 141.3%   
Long term debt Rs m078 0.0%   
Total assets Rs m22,24214,105 157.7%  
Interest coverage x38.041.4 91.8%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.4 217.3%   
Return on assets %12.37.6 162.1%  
Return on equity %15.28.4 180.8%  
Return on capital %19.911.6 171.7%  
Exports to sales %017.3 0.0%   
Imports to sales %7.37.8 93.7%   
Exports (fob) Rs mNA937 0.0%   
Imports (cif) Rs m1,348420 321.1%   
Fx inflow Rs m6,491937 692.4%   
Fx outflow Rs m1,348420 321.1%   
Net fx Rs m5,143518 993.8%   
CASH FLOW
From Operations Rs m2,3741,404 169.1%  
From Investments Rs m-2,592-2,982 86.9%  
From Financial Activity Rs m1,978-258 -766.8%  
Net Cashflow Rs m1,760-1,709 -103.0%  

Share Holding

Indian Promoters % 43.9 2.6 1,719.6%  
Foreign collaborators % 0.0 41.1 -  
Indian inst/Mut Fund % 20.3 29.5 68.8%  
FIIs % 15.6 22.5 69.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 56.2 56.4 99.6%  
Shareholders   237,377 73,034 325.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MARKSANS PHARMA. With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on MARKSANS PHARMA. vs ADVANCED ENZYME TECHNOLOGIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

MARKSANS PHARMA. vs ADVANCED ENZYME TECHNOLOGIES Share Price Performance

Period MARKSANS PHARMA. ADVANCED ENZYME TECHNOLOGIES S&P BSE HEALTHCARE
1-Day 0.46% -1.96% 1.18%
1-Month -0.72% -9.39% -0.75%
1-Year 109.61% 51.81% 61.82%
3-Year CAGR 45.11% -0.39% 18.16%
5-Year CAGR 43.62% 15.53% 19.79%

* Compound Annual Growth Rate

Here are more details on the MARKSANS PHARMA. share price and the ADVANCED ENZYME TECHNOLOGIES share price.

Moving on to shareholding structures...

The promoters of MARKSANS PHARMA. hold a 43.9% stake in the company. In case of ADVANCED ENZYME TECHNOLOGIES the stake stands at 43.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of MARKSANS PHARMA. and the shareholding pattern of ADVANCED ENZYME TECHNOLOGIES.

Finally, a word on dividends...

In the most recent financial year, MARKSANS PHARMA. paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 8.5%.

ADVANCED ENZYME TECHNOLOGIES paid Rs 5.0, and its dividend payout ratio stood at 53.8%.

You may visit here to review the dividend history of MARKSANS PHARMA., and the dividend history of ADVANCED ENZYME TECHNOLOGIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.